Related Experiment Video
Updated: Jun 1, 2026
05:28
Standardization of a Novel Semi-Automatic Software for Neurite Outgrowth Measurement
Published on: August 9, 2024
Structural diversity of neuritogenic substances and their application perspective
1College of Pharmaceutical Sciences, Zhejiang University, Yu Hang Tang Road, Hangzhou, China. qijianhua@zju.edu.cn
Mini Reviews in Medicinal Chemistry
|June 10, 2011
Summary
Small molecules, including natural and synthetic compounds, show promise as therapeutic drugs for neurodegenerative disorders due to their neurotrophic and neuroprotective effects. Further research into their structure-activity relationships could lead to new drug development.
Area of Science:
- Pharmacology
- Neuroscience
- Medicinal Chemistry
Background:
- Neurotrophic factors are crucial for neuronal survival and function.
- Neurodegenerative disorders represent a significant unmet medical need.
- Small molecular weight substances offer potential as therapeutic agents.
Purpose of the Study:
- To review the discovery and therapeutic potential of neuritogenic compounds.
- To explore the structural diversity and properties of these compounds.
- To highlight their neurotrophic and neuroprotective activities for drug development.
Main Methods:
- Literature review of natural and synthetic neuritogenic compounds.
- Analysis of structural features and chemical classes (terpenoids, lipids, alkaloids, etc.).
- Examination of reported neurotrophic and neuroprotective activities.
Main Results:
- Numerous natural and synthetic compounds exhibit neuritogenic properties.
- Compounds possess diverse structural scaffolds.
- Some compounds demonstrate both neurotrophic and neuroprotective effects.
Conclusions:
- Small molecular weight compounds are promising candidates for treating neurodegenerative diseases.
- Understanding structure-activity relationships is key to optimizing drug development.
- Further investigation supports their potential as therapeutic drugs.
